StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
Liquidia Corporation
NasdaqCM:LQDA
Sector
Location
Market Cap
USD 1.60 B
Share Price
USD 18.77
Avg Daily Volume
2,083,158
Change (1 day)
5.75%
Change (1 year)
65.52%
Change (YTD)
59.61%
Liquidia Corporation Shareholders' Equity for the year ending December 31, 2024: USD 77.28 M
Liquidia Corporation Shareholders' Equity is USD 77.28 M for the year ending December 31, 2024, a 63.40% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
-
Liquidia Corporation Shareholders' Equity for the year ending December 31, 2023 was USD 47.29 M, a -113.49% change year over year.
-
Liquidia Corporation Shareholders' Equity for the year ending December 31, 2022 was USD -350.60 M, a 13.25% change year over year.
-
Liquidia Corporation Shareholders' Equity for the year ending December 31, 2021 was USD -309.58 M, a 12.57% change year over year.
-
Liquidia Corporation Shareholders' Equity for the year ending December 31, 2020 was USD -275.00 M.
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Daiichi Sankyo Company, Limited
USD 24.62
4568.T
-0.30
-1.21%
Haleon plc
USD 4.93
HLN.L
+0.06
1.26%
Ucb S.A.
USD 210.11
UCB.BR
+0.83
0.40%
BeOne Medicines Ltd.
USD 296.46
ONC
+1.63
0.55%
Key Data
| Date | Shareholders' Equity | Cash and Short-Term Investments | Receivables | Inventory |
|---|
Competitors
Eli Lilly and Company
USD 805.43
LLY
+6.54
0.82%
AbbVie Inc.
USD 190.83
ABBV
+0.28
0.15%
Roche Holding AG
USD 352.25
RO.SW
+3.41
0.98%
AstraZeneca PLC
USD 147.28
AZN.L
+2.35
1.62%
Merck & Co., Inc.
USD 84.11
MRK
+0.13
0.15%
Amgen Inc.
USD 308.55
AMGN
-0.67
-0.22%
Pfizer Inc.
USD 25.35
PFE
-0.01
-0.04%
Gilead Sciences, Inc.
USD 113.20
GILD
-0.36
-0.32%
Sanofi
USD 100.09
SAN.PA
+0.48
0.48%
Bristol-Myers Squibb Company
USD 48.94
BMY
-0.04
-0.08%
Chugai Pharmaceutical Co., Ltd.
USD 49.80
4519.T
+0.60
1.22%
GSK plc
USD 18.78
GSK.L
+0.16
0.83%
Regeneron Pharmaceuticals, Inc.
USD 564.64
REGN
-7.75
-1.35%
Cencora, Inc.
USD 290.45
COR
-2.99
-1.02%
Jiangsu Hengrui Medicine Co., Ltd.
USD 8.04
600276.SS
+0.06
0.73%
Takeda Pharmaceutical Company Limited
USD 29.42
4502.T
-0.15
-0.50%
Daiichi Sankyo Company, Limited
USD 24.62
4568.T
-0.30
-1.21%
Haleon plc
USD 4.93
HLN.L
+0.06
1.26%
Ucb S.A.
USD 210.11
UCB.BR
+0.83
0.40%
BeOne Medicines Ltd.
USD 296.46
ONC
+1.63
0.55%